SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-18-045449
Filing Date
2018-08-20
Accepted
2018-08-20 08:31:45
Documents
3
Group Members
GL CAPITAL MANAGEMENT GP L.P.GL CHINA OPPORTUNITIES FUND L.P.GL PARTNERS CAPITAL MANAGEMENT LTDGL TRADE INVESTMENT LTDZHENFU LI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tv501354_sc13d.htm SC 13D 125710
2 EXHIBIT 1 tv501354_ex-1.htm EX-99.1 8727
3 EXHIBIT 2 tv501354_ex-2.htm EX-99.2 18890
  Complete submission text file 0001144204-18-045449.txt   155426
Mailing Address 18TH FL, JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT BEIJING F4 100125
Business Address 18TH FL, JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT BEIJING F4 100125 86-10-6598-3111
China Biologic Products Holdings, Inc. (Subject) CIK: 0001369868 (see all company filings)

IRS No.: 752308816 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83122 | Film No.: 181027186
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address UNIT 3001, CHINA WORLD TOWER 2 NO. 1 JIAN GUO MEN WAI AVENUE BEIJING F4 100004
Business Address UNIT 3001, CHINA WORLD TOWER 2 NO. 1 JIAN GUO MEN WAI AVENUE BEIJING F4 100004 861059611212
GL CAPITAL MANAGEMENT GP Ltd (Filed by) CIK: 0001667828 (see all company filings)

IRS No.: 980644714 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D